Announcement

Collapse
No announcement yet.

High Lassa virus seroprevalence in Upper Guinea, West Africa

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • High Lassa virus seroprevalence in Upper Guinea, West Africa

    Article first published online: 31 DEC 2012

    Seroepidemiological study reveals regional co-occurrence of Lassa- and Hantavirus antibodies in Upper Guinea, West Africa
    Abstract


    Objectives
    To assess the public health relevance of Lassa arenavirus and hantavirus infections in a subpopulation of recently febrile patients.

    Methods
    In a human seroprevalence study, we enrolled 253 participants on the basis of reported high fever during the last 3 months. They represented roughly 20% of the population of Bantou and Tanganya villages. Comprehensive serological screening and confirmatory assays (enzyme-linked immunosorbent assay, immunofluorescence assay, Western blot analysis) with several Lassa virus and hantavirus antigens were used to ensure high specificity and broad detection capacity.

    Results
    We found a Lassa IgG prevalence of 40.3% (102/253) and a hantavirus IgG prevalence of 1.2% (3/253). The Lassa IgM prevalence reached 2.8% (7/253).



    Conclusions

    High Lassa virus seroprevalence in recently febrile patients indicates that Lassa fever is a significant public health problem in the region. Human hantavirus infections also occur in the region but their public health relevance remains to be determined.



    LINK TO FULL ARTICLE

    ?Addressing chronic disease is an issue of human rights ? that must be our call to arms"
    Richard Horton, Editor-in-Chief The Lancet

    ~~~~ Twitter:@GertvanderHoek ~~~ GertvanderHoek@gmail.com ~~~
Working...
X